Cancer Registry Software Market by Type (Integrated Software, Standalone Software), Database Type (Commercial Databases, Public Databases), Functionality, Deployment, End User - Global Forecast 2023-2030

Cancer Registry Software Market by Type (Integrated Software, Standalone Software), Database Type (Commercial Databases, Public Databases), Functionality, Deployment, End User - Global Forecast 2023-2030

The Cancer Registry Software Market is projected to reach USD 193.47 million by 2030 from USD 78.36 million in 2022, at a CAGR of 11.96% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Cancer Registry Software Market.
  • Based on Type, market is studied across Integrated Software and Standalone Software. The Integrated Software is projected to witness significant market share during forecast period.
  • Based on Database Type, market is studied across Commercial Databases and Public Databases. The Commercial Databases is projected to witness significant market share during forecast period.
  • Based on Functionality, market is studied across Cancer Reporting, Medical Research & Clinical Studies, Patient Care Management, and Product Outcome Evaluation. The Patient Care Management is projected to witness significant market share during forecast period.
  • Based on Deployment, market is studied across On-Cloud and On-Premise. The On-Cloud is projected to witness significant market share during forecast period.
  • Based on End User, market is studied across Government Organizations & Third-Party Administrators, Hospitals & Medical Practices, Private Payers, and Research Centers. The Research Centers is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Cancer Registry Software Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Cancer Registry Software Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Cancer Registry Software Market, highlighting leading vendors and their innovative profiles. These include C/Net Solutions, Conduent, Inc., Dacima Software Inc., Elekta AB, ERS, Inc., IBM Corporation, Inspirata, Inc., IQVIA Inc, Mckesson Corporation, NAACCR, Inc., NeuralFrame, Inc, NextPath LLC, Omega Healthcare, Onco, Inc., Ordinal Data, Inc, Q-Centrix, LLC, Rocky Mountain Cancer Data Systems, and Siemens Healthineers AG.

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Cancer Registry Software Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Cancer Registry Software Market?
  3. What is the competitive strategic window for identifying opportunities in the Cancer Registry Software Market?
  4. What are the latest technology trends and regulatory frameworks in the Cancer Registry Software Market?
  5. What is the market share of the leading vendors in the Cancer Registry Software Market?
  6. Which modes and strategic moves are suitable for entering the Cancer Registry Software Market?

Note: PDF & Excel + Online Access - 1 Year

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cancer Registry Software Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers Surge in prevalences of cancer across the world Growing adoption of electronic health records Increasing demand for cloud-based cancer patients registry software solutions
5.1.2. Restraints Lack of awareness about cancer registry software among end-users
5.1.3. Opportunities Surge in the government initiatives for development of cancer registry software Technological developments in the cancer registry software solutions
5.1.4. Challenges Concern over security and privacy of data
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Cancer Registry Software Market, by Type
6.1. Introduction
6.2. Integrated Software
6.3. Standalone Software
7. Cancer Registry Software Market, by Database Type
7.1. Introduction
7.2. Commercial Databases
7.3. Public Databases
8. Cancer Registry Software Market, by Functionality
8.1. Introduction
8.2. Cancer Reporting
8.3. Medical Research & Clinical Studies
8.4. Patient Care Management
8.5. Product Outcome Evaluation
9. Cancer Registry Software Market, by Deployment
9.1. Introduction
9.2. On-Cloud
9.3. On-Premise
10. Cancer Registry Software Market, by End User
10.1. Introduction
10.2. Government Organizations & Third-Party Administrators
10.3. Hospitals & Medical Practices
10.4. Private Payers
10.5. Research Centers
11. Americas Cancer Registry Software Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cancer Registry Software Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Cancer Registry Software Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. C/Net Solutions
15.1.2. Conduent, Inc.
15.1.3. Dacima Software Inc.
15.1.4. Elekta AB
15.1.5. ERS, Inc.
15.1.6. IBM Corporation
15.1.7. Inspirata, Inc.
15.1.8. IQVIA Inc
15.1.9. Mckesson Corporation
15.1.10. NAACCR, Inc.
15.1.11. NeuralFrame, Inc
15.1.12. NextPath LLC
15.1.13. Omega Healthcare
15.1.14. Onco, Inc.
15.1.15. Ordinal Data, Inc
15.1.16. Q-Centrix, LLC
15.1.17. Rocky Mountain Cancer Data Systems
15.1.18. Siemens Healthineers AG
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings